Skip to main content
Annals of Medicine and Surgery logoLink to Annals of Medicine and Surgery
. 2023 Oct 2;85(11):5809–5812. doi: 10.1097/MS9.0000000000001380

Dilemma in diagnosing incomplete Kawasaki disease in a resource limited setting

Mukesh Bhatta a, Aashish Baniya b, Diwakar Koirala b,*, Karun Bhattarai b, Abhishek Shah b
PMCID: PMC10617906  PMID: 37915681

Abstract

Introduction and importance:

Kawasaki disease (KD) is an acute febrile systemic vasculitis that predominantly affects small to medium sized vessels and mostly occurs in children below 5 years of age. The morbidity and mortality mostly occur due to cardiac involvement.

Case presentation:

The authors present a case of a 5-year-old male child from hilly region of Nepal who presented with fever for 7 days along with strawberry tongue and non-exudative conjunctivitis without rashes, extremity changes or lymphadenopathy. A suspicion of incomplete KD (IKD) was made. The notable investigation findings were increased erythrocyte sedimentation rate, C-reactive protein, leucocyte count and platelets. Echocardiography showed normal findings. Based on the clinical features and supplemental laboratory findings, a diagnosis of IKD was made. The patient improved after intravenous immunoglobulin and Aspirin.

Clinical discussion:

The main learning objective that the authors get from this case is the challenges in the diagnosis of IKD in the resource limited setting like Nepal. Whether or not to start intravenous immunoglobulin is a dilemma for the physician in most of the cases of suspected IKD, due to the high cost and poor availability of intravenous immunoglobulin in this setting. Hence, the use of inflammatory markers, supplemental laboratory findings together with the few diagnostic criteria met by the patient helps in making a diagnosis and institute timely treatment with intravenous immunoglobulin and aspirin.

Conclusion:

Diagnosis of KD in difficult in resource limited setting.

Keywords: diagnosis dilemma, incomplete Kawasaki disease, Kawasaki disease, resource limited setting

Introduction

Highlights

  • Our study highlights the difficulty faced by the paediatrists during the diagnosis of incomplete Kawasaki disease (KD) in resource limited setting like Nepal.

  • The lack of proper laboratory parameter for the incomplete KD diagnosis makes it difficult for the confirmation of the diagnosis.

  • Further challenges is added due to lack of paediatric cardiologist and rheumatologist.

  • Our research holds value in understanding and keeping KD as a differential diagnosis whenever a child presents with Fever not relieved by medication for more than 5 days so, that the diagnosis is not missed and life of the child is not risked.

Kawasaki disease (KD) is an acute febrile systemic vasculitis that predominantly affects small to medium sized vessels and mostly occurs in children below 5 years of age1. The bulk of morbidity and mortality in KD are caused by cardiac involvement, which results in the development of coronary artery aneurysms, myocarditis, shock, heart failure, impaired ventricular function, and ischaemic heart disease as a result of inflammatory vasculitic changes in and around the heart and arrhythmias. KD used to be referred to as mucocutaneous lymph node syndrome1.

There are multiple possible triggers hypothesized in the causation and pathogenesis of KD. Rife et al. 2 in their study mentioned about various factors like genetic, post-vaccine exposure, post-infectious or immune dysregulation, as possible triggers. However, exact mechanism is still unknown.

The progression of cardiovascular involvement of KD3 includes a spectrum of changes ranging from mild transient dilation of coronary artery which could be remodelled to normal upon treatment, to aneurysm formation leading to thrombotic occlusion, which could either recanalize later or might lead to permanent occlusion with stenosis or abnormal vascular wall remodelling.

Table 1 defines the diagnostic criteria for KD4.

Table 1.

Diagnostic criteria for Kawasaki disease

Diagnostic criteria:
 Fever for 5 or more days, 4 or more diagnostic criteria are met, and absence of viral or bacterial causes for symptoms. The 5 key criteria are as follows:
 Rash: maculopapular, diffuse erythroderma, or erythema multiforme–like
 Oral changes: erythema and cracking of lips, strawberry tongue, and/or erythema of oral and pharyngeal mucosa
 Conjunctivitis: bilateral bulbar conjunctival injection without exudate
 Extremity changes: erythema and oedema of hands and feet in acute phase and/or periungual desquamation in subacute phase
 Cervical lymphadenopathy (1.5 cm or more in diameter); typically, unilateral

NS1, Nonstructural protein 1.

If 4 or more principal criteria are present, the diagnosis may be made on day 4 (or, rarely, even day-3) of fever.

Incomplete KD (IKD) Criteria: Fever for 5 or more days and failure to meet at least 4 of 5 diagnostic criteria for complete KD.

The overall prevalence of KD was found to be 0.10% Interval (0.07–0.13%) among 11 416 patients under the age of 5 years admitted in paediatric ward in Nepal5. At diagnosis, the median age was 10.5 months. The four symptoms that were most frequently seen were fever, rash, and oral abnormalities5.

KD is primarily a self-limiting monophasic disease whose outcome depends on the swift diagnosis and administration of Intravenous Immunoglobulin (IVIG), within 10 days of symptoms onset which additionally helps in preventing organ dysfunction and shortening the duration of inflammation1. The major complications of the disease includes (but not limiting to): KD shock syndrome6, myocardial infarction7, non-coronary vascular involvement8, macrophage activation syndrome9.

Case presentation

History and examination

A 5-year-old male from hilly region of Nepal presented to a tertiary hospital with a high-grade fever for 7 days(103°F) accompanied byredness of eyes (Fig. 1), strawberry-coloured tongue, myalgia, anorexia. He had no history of rash, erythema of palms and soles, skin desquamation, any sick contacts, urinary urgency, frequency or burning micturition; shortness of breath, cough and chest pain; altered consciousness, focal neurological deficits and recent travel. Fever was not responding to oral paracetamol. On examination, at initial presentation, he was febrile and appeared unwell. Vitals were: pulse rate: 102 beats per minute, respiratory rate: 30 cycles per minute, capillary refill time was less than 3 s, temperature: 102°F. On general examination there was no pallor, icterus, cyanosis, clubbing, lymphadenopathy, oedema and dehydration. Tongue was erythematous giving a strawberry like appearance. Non-exudative Conjunctivitis was present. Throat and pharynx were normal. Chest examination had normal vesicular breath sounds bilaterally. Cardiovascular examination revealed normal heart sounds without murmur. Abdominal and neurological examinations were well within normal limits (Figure 2).

Figure 1.

Figure 1

Non-exudative conjunctivitis.

Figure 2.

Figure 2

No cervical lymphadenopathy.

On investigations

His initial investigations are listed in Table 2.

Table 2.

Investigations done

Investigations Results Normal values
Haemoglobin 11.0 g/dl Male: 13.5–16.5 and female: 12–16 g/dl
Total leucocyte count (TLC) 15 920 cells/mm3 4500–11 000/mm3
Erythrocyte sedimentation rate (ESR) 38 mm/h Male: 0–15 mm/h and female: 0–20 mm/h
Platelets 510 000/mm3 150 000–400 000/mm3
Alanine transaminase (ALT) 61.0 U/l 8–20 U/l
Aspartate transaminase (AST) 52.0 U/l 25–125 U/l
Alkaline phosphatase (ALP) 156 U/l 20–70 U/l
Total bilirubin 0.37 mg/dl (0.1–1.0 mg/dl)
Conjugated bilirubin 0.07 mg/dl 0.0–0.3 md/dl
Albumin 3 g/dl 3.5–5.5 g/dl
Blood film Normal
Creatinine 0.34 mg/dl 0.6–1.2 mg/dl
Urine-microscopy, culture and sensitivity Culture sterile after 24 h of aerobic incubation at 37°C
Dengue serology: NS1, IgM, IgG Negative
Troponin-I Negative
Echocardiography Normal
C-reactive protein (CRP) 96 mg/l 8–10 mg/dl
COVID-19 PCR Negative

Note: The Normal lab value of the respective hospital has been used.

It should be noted that dengue serology was done because the patient was from Dengue Endemic region.

IgG, immunoglobulin G, IgM, immunoglobulin M; NS1,Nonstructural protein 1; PCR, polymerase chain reaction.

Diagnosis and treatment

There was a difficulty in making a confident diagnosis of IKD as the patient met only two out of the five criteria. Also, there was a dilemma in using or not using IVIG in this patient, given the fact that that it is expensive and easily not available. The risks associated with not using IVIG were also weighed. Considering a raised C-reactive protein and erythrocyte sedimentation rate value, along with leukocytosis, thrombocytosis and hypoproteinemia in conjunction with fever of 7 days duration and presence of strawberry tongue and non-exudative conjunctivitis, a diagnosis of IKD was made and a decision of starting IVIG and aspirin therapy was done. Serum immunoglobulin G level was not tested in the patient because of unavailability and cost factor. It should be noted that these laboratory findings were not considered as diagnostic criteria. They rather supported our diagnosis. Hence, it was diagnosed as IKD.

The treatment was started on second day with IVIG at dose of 2 g/kg in infusion over 10–12 h and aspirin at a dose of 80 mg/kg/day along with oral paracetamol. IV antibiotic Ceftriaxone was given 1 g IV in two divided doses for 7 days. Paracetamol was given for decreasing fever.

Outcomes

On day-3 after the medication, fever subsided and vitals were improved.

Discussion and conclusions

This child of IKD primarily presents with fever, strawberry tongue and conjunctivitis, along with raised inflammatory markers, anaemia, leukocytosis, thrombocytosis, hypoalbuminemia and mildly raised liver enzymes, with normal initial echocardiogram, contrary to the usual cardiac findings contemplated in literatures1. The most important complication of KD arises as a result of coronary artery involvement, which leads to cardiac arrythmia, aneurysm, ischaemic heart disease, and sudden death5. However, the clinical course of KD is highly variable and there exists no pathognomonic clinical or laboratory findings to help diagnose KD.

The diagnosis of KD in this case was made using the American Heart Association criteria5. In the presence of at least 5 days of fever, if there are at least four of the five principal criteria (cervical adenopathy, bilateral non-purulent conjunctivitis, oropharyngeal mucosal changes, polymorphous rash, erythema of the palms or soles, and oedema of the hands or feet). IKD is a dangerous diagnostic dilemma, as children present with prolonged fever and do not meet all of the clinical criteria for complete KD diagnosis; since the patient meets two out of five principal criteria he is diagnosed as having IKD.

There have been various studies and case reports in the past describing the varied manifestations of IKD. Pratap et al. 10 described KD in an adult with predominant hepatic involvement which is rare. Hu C et al. 11 reported KD in a 4 years old boy with predominant gastrointestinal symptoms with signs of gastrointestinal haemorrhage on Endoscopy. In another report by Liu et al. 12, they described KD in a 2 years girl child with predominant respiratory symptoms diagnosed with KD shock syndrome who was treated with extracorporeal membrane oxygenation and eventually recovered completely. KD in a 7-years-old girl with predominant respiratory symptoms with provisional diagnosis of pneumonia with pleural effusion not responding to antibiotics was mentioned by Arslanoglu et al. 13. Osman et al. 14 reported KD in a 7 months fully vaccinated Asian-boy with non-bilious, non-projectile vomiting with passage of bloody mucoid stool diagnosed with intussusception which was manually reduced on laparotomy. Similarly, another case report by Lin et al. 15 mentioned KD in a 5 months old boy with fever and symptoms of KD shock syndrome and hepatosplenomegaly with decreased red blood cells and platelets giving the diagnosis of macrophage activation syndrome, which was managed by emergency shock therapy and methyl prednisolone.

IKD diagnosis is often late and confusing which often worsens the prognosis of the child. Li T et al. 16 mentions the difficulty of diagnosis of IKD due to its occurrence with other infections and rheumatic diseases. Hence, any child presenting with unexplained fever for longer duration clinician should be vigilant for possibility with KD or IKD.

Miller et al. 17 described a case of 4-year boy presented with skin changes of lips and oral cavity, generalized rash, oedema of hands and feet and peeling of skin of periungual areas of fingers as well as of groyne and perianal area, who was diagnosed with IKD after investigations and cardiologist consultation. As explained in the literature the diagnosis was challenging without the help from cardiologist consultation. Idris et al. 18 reported a case of 4-month female with fever for less than 4 days and not following the latest American Heart Association guideline for IKD but was diagnosed as IKD after cardiologist consultation and echocardiogram which revealed coronary artery aneurysm. As mentioned in the literature even with resources available, the diagnosis was delayed by 10 days giving evidence to its challenging diagnosis. Pilania et al. 19 emphasized about the difficulty in diagnosis of KD in older child. The authors further added that delay in diagnosis is associated with higher risk of coronary abnormalities. Also, the absence of a confirmatory laboratory marker creates further difficulties in diagnosis of KD. The findings of Pilania and colleagues are similar to that of Vervoort et al. 20.

Moreover, the diagnosis becomes tricky in resource limited setting like Nepal where the cost factor of IVIG and limited availability makes the decision making challenging and time consuming. The problem is added further in our setting due to lack of paediatric rheumatologist and paediatric cardiologist in our setting. Among the dilemma in diagnosis and dilemma in cost, the former is the first priority to be addressed.

Methods

The work has been reported in line with the SCARE criteria21.

Ethics approval and consent to participate

Not applicable for case reports.

Consent for publication

The consent for publication was obtained from the Legal Guardian of the Patient.

Source of funding

No funding sources.

Author contribution

M.B.: analyzed and interpreted the data, conceptualization, investigations, visualization, supervision, writing—review and editing. A.B.: data curation, writing—original draft, writing—review and editing. D.K.: data curation, writing—original draft, writing—review and editing. K.B.: data curation, writing—original draft, writing— review and editing. A.S.: data curation, writing—original draft, writing—review and editing. All authors read and approved the final manuscript.

Conflicts of interest disclosure

The authors declare that they have no competing interests.

Guarantor

All the authors are guarantor.

Availability of data and materials

Not applicable.

Provenance and peer-reviewed

Not commissioned, externally Peer-reviewed.

Footnotes

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Published online 2 October 2023

Contributor Information

Mukesh Bhatta, Email: mukacebhatta@gmail.com.

Aashish Baniya, Email: aashishbaniya0010@gmail.com.

Diwakar Koirala, Email: diwakarkoirala1@gmail.com.

Karun Bhattarai, Email: anelitekarun99@gmail.com.

Abhishek Shah, Email: dr.shabhishek@gmail.com.

References

  • 1.Agarwal S, Agrawal DK. Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol 2017;13:247–258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rife E, Gedalia A. Kawasaki disease: an update. Curr Rheumatol Rep 2020;22:1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. J Am College Cardiol 2016;67:1738–1749. [DOI] [PubMed] [Google Scholar]
  • 4.McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals From the American Heart Association. Circulation 2017;135:e934. [DOI] [PubMed] [Google Scholar]
  • 5.Rajak K, Twayana AR, Shrestha R, et al. Prevalence of Kawasaki disease in a tertiary care hospital: a descriptive cross-sectional study. J Nepal Med Assoc 2019;57:409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Marchesi A, Tarissi de Jacobis I, Rigante D, et al. Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. Ital J Pediatr 2018;44:103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brogan PA. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Childhood 2002;86:286–290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bayers S, Shulman ST, Paller AS. Kawasaki disease: Part II. Complications and treatment. J Am Acad Dermatol 2013;69:513, e1–518. [DOI] [PubMed] [Google Scholar]
  • 9.Gorelik M, Chung SA, Ardalan K, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthr Rheumatol 2022;74:586–596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pratap K, Gardner LS, Gillis D, et al. Hepatic predominant presentation of Kawasaki disease in adolescence case report and review of literature. BMC Gastroenterol 2020;20:3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hu C, Yu Y. Gastrointestinal hemorrhage before anticoagulant therapy in Kawasaki disease: a case report. BMC Pediatr 2020;20:1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liu J, Yang C, Zhang Z, et al. Kawasaki disease shock syndrome with acute respiratory distress syndrome in a child: a case report and literature review. BMC Pulmonary Med 2022;22:1–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Arslanoglu Aydin E, Demir S, Aydin O, et al. Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature. J Med Case Rep 2019;13:1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Osman RS, Salum HM, Noorani M. Kawasaki disease presenting after intussusception: a case report. J Med Case Rep 2021;15:1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lin Y, Shi L, Deng Y, et al. Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy. Medicine 2019;98:e14203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Li T, Feng J, Li N, et al. Correct identification of incomplete Kawasaki disease. The. J Int Med Res 2021;49:3000605211001712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Miller MM, Miller AH. Incomplete Kawasaki disease. Am J Emerg Med 2013;31:894.e5–7. [DOI] [PubMed] [Google Scholar]
  • 18.Idris I, Awadelkarim AM, Saad E, et al. Incomplete Kawasaki disease in an infant: a case report and literature review. Cureus 2022;14:1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Pilania RK, Bhattarai D, Singh S. Controversies in diagnosis and management of Kawasaki disease. World J Clin Pediatrics 2018;7:27–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Vervoort D, Donné M, Van Gysel D. Pitfalls in the diagnosis and management of Kawasaki disease: an update for the pediatric dermatologist. Pediatr Dermatol 2018;35:743–747. [DOI] [PubMed] [Google Scholar]
  • 21.Agha RA, Franchi T, Sohrabi C, et al. for the SCARE Group . The SCARE 2020 Guideline: Updating Consensus Surgical CASE REPORT (SCARE) Guidelines. Int J Surg 2020;84:226–230. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from Annals of Medicine and Surgery are provided here courtesy of Wolters Kluwer Health

RESOURCES